Patent details

EP3072907 Title: ANTI-HER2 ANTIBODY AND CONJUGATE THEREOF

Basic Information

Publication number:
EP3072907
PCT Application Number:
CN2014091332
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148640535
PCT Publication Number:
WO2015074528
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-HER2 ANTIBODY AND CONJUGATE THEREOF
French Title of Invention:
ANTICORPS ANTI-HER2 ET SON CONJUGUÉ
German Title of Invention:
ANTIKÖRPER GEGEN HER2 UND KONJUGAT DARAUS
SPC Number:

Dates

Filing date:
18/11/2014
Grant date:
20/02/2019
EP Publication Date:
28/09/2016
PCT Publication Date:
28/05/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/02/2019
EP B1 Publication Date:
20/02/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/11/2019
Expiration date:
18/11/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/02/2019
 
 

Name:
REMEGEN, LTD
Address:
58 Middle Beijing Road Yantai Economic & Technological Development Area, Yantai, Shandong 264006, China (CN)

Inventor

1

Name:
FANG, Jianmin
Address:
China (CN)

2

Name:
XU, Qiaoyu
Address:
China (CN)

3

Name:
JIANG, Jing
Address:
China (CN)

4

Name:
LI, Zhuanglin
Address:
China (CN)

5

Name:
YAO, Xuejing
Address:
China (CN)

6

Name:
HUANG, Changjiang
Address:
China (CN)

7

Name:
LI, Hongwen
Address:
China (CN)

Priority

Priority Number:
201310586326
Priority Date:
19/11/2013
Priority Country:
China (CN)

Classification

IPC classification:
C07K 16/32; A61K 47/68;

Publication

European Patent Bulletin

Issue number:
201908
Publication date:
20/02/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages